Αρχειοθήκη ιστολογίου

Πέμπτη 22 Νοεμβρίου 2018

The efficacy of neutron radiation therapy in treating salivary gland malignancies

Publication date: January 2019

Source: Oral Oncology, Volume 88

Author(s): Mari-Alina Timoshchuk, Preston Dekker, Daniel S. Hippe, Upendra Parvathaneni, Jay J. Liao, George E. Laramore, Jasjit K. Dillon

Abstract
Objectives

Radiation therapy is commonly used to treat head and neck malignancies. While there is abundant research regarding photon radiation therapy, literature on neutron radiotherapy (NRT) and oral complications is limited. This study aims to determine: (1) the 6-year and 10-year locoregional control and survival rates, (2) factors associated with locoregional control and survival and (3) the frequency of oral complications in patients undergoing NRT for salivary gland malignancies.

Materials and methods

This is a retrospective cohort study. The sample was composed of patients with salivary gland malignancies treated with NRT between 1997 and 2010. Data were extracted from patient charts, telephone surveys, and social security records. Multivariate competing risk and Cox regression models were used to assess predictors of locoregional control and survival.

Results

The sample was composed of 545 subjects with a mean age of 54.2 years (±16). The predominant tumor and location were adenoid cystic carcinoma (47%) and the parotid (56%). Multivariate analysis indicated that positive surgical margins, biopsied/inoperable malignancies, neck involvement, and lymphovascular invasion were prognostic risk factors associated with decreased survival. The 6- and 10-year locoregional control rates were 84% and 79%. The 6- and 10-year survival rates were 72% and 62%. Osteoradionecrosis developed in 3.4% of subjects.

Conclusions

The 6- and 10-year locoregional control and survival rates compare favorably to rates reported for conventional photon radiation. Osteoradionecrosis rates were comparable to that of photon radiation treatment (2–7%). Given the potential benefits of NRT, healthcare professionals should be educated regarding its indications and oral complications.



https://ift.tt/2Kq6HrV

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου